Medical device maker MicroTransponder has completed a $53 million Series E financing round led by US Venture Partners.
The raise also included participation from GPG Ventures, Exceller Hunt Ventures, Osage University Partners, Action Potential Venture Capital and the Vertical Group. The company said it will use the capital to market its Vivistim vagus nerve stimulation system, an implantable device that aims to improve hand and arm mobility in stroke patients.
“Our investors are energized by MicroTransponder’s vision to enable treatment for the millions of stroke survivors who have persistent moderate to severe upper limb impairment. Our goal has always been to make Vivistim Paired VNS the gold standard for Rehabilitation after stroke. Today this therapy can help more stroke survivors return to the daily activities, hobbies and experiences they love,” CEO and Director Richard Fousto said in a statement.
Grandma Fertility emerged from stealth last week with $37.5 million, including $29 million in equity and another $8.5 million in debt financing.
The seed and Series A rounds were led by JAZZ Venture Partners, Root Ventures, Mithril Capital, Global Asset Capital and Free Solo Ventures. The debt facility came from Silicon Valley Bank. The fertility startup’s first product aims to identify the healthiest sperm to improve IVF results.
“Grandma Fertility is leveraging the opportunity to bring advanced technological advancements into the fertility space and meet the demands of rising infertility rates,” co-founder and CEO Gurjeet Singh said in a statement. “Our mission is to improve outcomes for more families dealing with fertility issues and we strive to create a place where everyone who wants to have a child has access to the most advanced, successful fertility treatments.”
Payer-focused healthcare data startup Abacus Insights raised $28 million in Series C funding, bringing total revenue to $81 million.
The round was led by MultiPlan Corporation with participation from Blue Venture Fund, CRV, .406 Ventures, Horizon Healthcare Services Inc. and Echo Health Ventures. Abacus Raised $35 million in Series B financing in 2020.
It plans to use the investment to grow its business, improve its platform and hire more staff.
“This new funding validates our company’s mission to help health plans unlock health data,” said CEO and founder Dr. Minal Patel in a statement. “It allows consumers to make better health choices and doctors to make more informed treatment decisions. Payers are also using the platform to increase efficiencies in their business, further reducing costs for their members. We are proud to partner with MultiPlan, given their leadership in data and analytics serving nearly every payer in the country.”
Self-paying healthcare market Sesame has raised $27 million in a Series B round led by GV.
Virgin Group, TeleSoft Partners, FMZ Ventures, General Catalyst, Industry Ventures, Coefficient Capital, Giant Ventures and Alumni Ventures Group also participated in the increase. Sesam plans to use the capital to grow the startup and launch its subscription program outside of beta.
“Sesame provides greater access to healthcare for a meaningful percentage of the population, and we are inspired by the company’s mission to achieve better patient outcomes for underserved communities,” said Cathy Friedman, executive venture partner at GV, in a statement.
“Sesame presents an exciting opportunity to develop a dynamic market at a scale unlike the current US healthcare ecosystem. We are excited to partner with David Goldhill and the entire Sesame team as they navigate this next phase of growth.” enter.”